Di Qu

512 total citations
24 papers, 389 citations indexed

About

Di Qu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Di Qu has authored 24 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Di Qu's work include Immune Cell Function and Interaction (5 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Di Qu is often cited by papers focused on Immune Cell Function and Interaction (5 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Di Qu collaborates with scholars based in China and France. Di Qu's co-authors include Dawei Huang, Jingshu Geng, Yina Gao, Jiping Qi, C. Trépo, Françoise Berby, Qiu-Yue Han, Yang Fang, Kejun Nan and Dan Lu and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

Di Qu

22 papers receiving 379 citations

Peers

Di Qu

HEPAT

EPIDE

ONCOL

Nicoletta Bertino Italy

Xin Yin China

Hua Sun China

Lei Lyu China

Pradhyumna Muralidharan India

Aitor Esparza-Baquer Spain

Álvaro Santos‐Laso Spain

Xiaoqiang Chai China

H Ohmori Japan

Upik Anderiani Miskad Indonesia

Nicoletta Bertino Italy

Di Qu

89 ×0.5

147 ×1.4

HEPAT

128 ×1.3

EPIDE

64 ×0.7

ONCOL

78 ×0.9

Citations per year, relative to Di Qu Di Qu (= 1×) peers Nicoletta Bertino

Countries citing papers authored by Di Qu

Since Specialization

Citations

This map shows the geographic impact of Di Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Qu more than expected).

Fields of papers citing papers by Di Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Qu. The network helps show where Di Qu may publish in the future.

Co-authorship network of co-authors of Di Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Di Qu. A scholar is included among the top collaborators of Di Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Qu. Di Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ke-Cheng, et al.. (2024). Ginseng-DF ameliorates intestinal mucosal barrier injury and enhances immunity in immunosuppressed mice by regulating MAPK/NF-κB signaling pathways. European Journal of Nutrition. 63(5). 1487–1500. 3 indexed citations

Liu, Wei, Xiaoke Sun, Yun Bai, et al.. (2024). RNA-seq shows Angiopoietin-like 4 promotes hepatocellular carcinoma progression by inducing M2 polarization of tumor-associated macrophages. International Journal of Biological Macromolecules. 287. 138523–138523.

Zhang, Baolu, Di Qu, Hao Wang, et al.. (2024). ACSS2 enables melanoma cell survival and tumor metastasis by negatively regulating the Hippo pathway. Frontiers in Molecular Biosciences. 11. 3 indexed citations

Cui, Guang‐Hua, et al.. (2023). Postoperative pathological complete response in a patient with PD‑L1‑negative stage IIIB lung squamous cell carcinoma following neoadjuvant tislelizumab treatment combined with chemotherapy: A case report and literature review. Oncology Letters. 26(3). 388–388. 4 indexed citations

Bai, Yun, Di Qu, Dan Lu, et al.. (2022). Pan‐cancer landscape of abnormal ctDNA methylation across human tumors. Cancer Genetics. 268-269. 37–45. 1 indexed citations

Qu, Di, Luomiao Yang, Jingguo Wang, et al.. (2022). Identification and Functional Analysis of the Caffeic Acid O-Methyltransferase (COMT) Gene Family in Rice (Oryza sativa L.). International Journal of Molecular Sciences. 23(15). 8491–8491. 49 indexed citations

Qu, Di, Huihui� Guo, & Yanan Xu. (2021). Effects of Tranilast on Inflammasome and Macrophage Phenotype in a Mouse Model of Myocardial Infarction. Journal of Interferon & Cytokine Research. 41(3). 102–110. 4 indexed citations

Cui, Ying, Jinghao Wang, Shanshan Liu, et al.. (2019). miR‐216a promotes breast cancer cell apoptosis by targeting PKCα. Fundamental and Clinical Pharmacology. 33(4). 397–404. 23 indexed citations

Qu, Di, et al.. (2019). Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy. Medical Oncology. 36(10). 84–84. 8 indexed citations

10.

Qu, Di, et al.. (2019). NK cell‑produced IFN‑γ regulates cell growth and apoptosis of colorectal cancer by regulating IL‑15. Experimental and Therapeutic Medicine. 19(2). 1400–1406. 23 indexed citations

11.

Qu, Di, et al.. (2019). The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment. Disease Markers. 2019. 1–5. 10 indexed citations

12.

Qu, Di, et al.. (2018). DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis. Cancer Science. 110(1). 157–165. 22 indexed citations

13.

Wang, Jing‐Hao, et al.. (2017). Upregulation of microRNA-143 reverses drug resistance in human breast cancer cells via inhibition of cytokine-induced apoptosis inhibitor 1. Oncology Letters. 13(6). 4695–4700. 8 indexed citations

14.

Lu, Dan, et al.. (2016). Prediction of miRNAs targeting cytokine induced apoptosis inhibitor 1 and their expression in multidrug-resistant breast cancer cell lines. 28(11). 735–738.

15.

Ji, Jingjing, et al.. (2013). Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells. Journal of Cancer Research and Therapeutics. 9(7). 162–162. 6 indexed citations

16.

Fang, Yang, Yina Gao, Jingshu Geng, et al.. (2013). Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.. PubMed. 6(12). 2846–54. 46 indexed citations

17.

Zeng, Min, et al.. (2001). [The inhibitory effect of oxymatrine on hepatitis C virus in vitro].. PubMed. 9 Suppl. 12–4. 19 indexed citations

18.

Qu, Di, Jisu Li, Ludmila Vitvitski, et al.. (1994). Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II. Journal of Hepatology. 21(1). 70–75. 59 indexed citations

19.

Trépo, C., et al.. (1994). Limites du diagnostic immunosérologique et moléculaire de l'hépatite C. Nuclear Medicine and Biology. 21(3). 419–431. 1 indexed citations

20.

Qu, Di, J P Lamelin, S de Sanjosé, et al.. (1994). Serological responses to different genotypes of hepatitis C virus in France. Journal of Clinical Microbiology. 32(1). 211–212. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact